| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |